Stock Events

Stock Events

Qrons 

$0.011100
4
-$0.00-0.89%Wednesday 13:30

Statistics

Day High
0.0111
Day Low
0.0111
52W High
0.173
52W Low
0.0111
Volume
100
Avg. Volume
82
Mkt Cap
198,856.5
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 14Expected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.06
-0.04
-0.01
0.01
Expected EPS
N/A
Actual EPS
0.01

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-56,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap37.49B
Biogen is a biotechnology company that focuses on discovering, developing, and delivering therapies for neurological diseases, directly competing with Qrons' focus on brain injuries and disorders.
Novavax
NVAX
Mkt Cap1.66B
Novavax is involved in the development of vaccines and healthcare products that could compete with Qrons' therapeutic approaches for brain health.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies in areas that overlap with Qrons' interests, including treatments for viral diseases that could affect the brain.
Moderna
MRNA
Mkt Cap88.52B
Moderna is known for its mRNA technology, which could be applied to neurological conditions, potentially competing with Qrons' innovative approaches to brain injuries.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company with a broad portfolio that includes treatments for neurological conditions, making it a competitor in the brain health space.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie has a strong focus on neuroscience, including research and development in areas related to brain health, which competes with Qrons' objectives.
AMGEN
AMGN
Mkt Cap251.94B
Amgen focuses on human therapeutics, including treatments for neurological disorders, positioning it as a competitor to Qrons in the biotech and healthcare industry.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly and Company has a significant presence in the neuroscience field, including developing treatments for brain-related conditions, directly competing with Qrons' mission.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals is involved in developing treatments for serious medical conditions, including those affecting the brain, making it a competitor to Qrons.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company with a diverse portfolio that includes innovative medicines for neurological conditions, competing with Qrons in the area of brain health.

About

Qrons, Inc. is a biotechnology company, which engages in the development of treatments and technologies for neuronal and infectious diseases. Its proprietary patents include Techniques for Promoting Neuronal Recovery, Therapeutic Polypseudorotaxane Hydrogels, and Tellurium Compositions and Techniques for Use Therewith. The company was founded by Jonah Martin Meer and Ido Merfeld on August 22, 2016 and is headquartered in Glendale, CA.
Show More
CEO
Cory J. Rosenberg
Employees
1
Country
United States
ISIN
US74737F1012

Listings

OTC Link
US
QRON

0 Comments

Share your thoughts

FAQs

What is Qrons stock price today?▼
The current price of QRON is $0.01 USD — it has decreased by -0.89% in the past 24 hours. Watch Qrons stock price performance more closely on the chart.
What is Qrons stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Qrons stocks are traded under the ticker QRON.
Is Qrons stock price growing?▼
QRON stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Qrons has showed a +0% increase.
What is Qrons market cap?▼
Today Qrons has the market capitalization of 198,856.5
What were Qrons earnings last quarter?▼
QRON earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Qrons revenue for the last year?▼
Qrons revenue for the last year amounts to 0 USD.
What is Qrons net income for the last year?▼
QRON net income for the last year is -56,000 USD.
How many employees does Qrons have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Qrons located?▼
Qrons operates in the Health & Wellness sector.
When did Qrons complete a stock split?▼
Qrons has not had any recent stock splits.
Where is Qrons headquartered?▼
Qrons is headquartered in Glendale, United States.